SODIUM ACETATE
SODIUM ACETATE Injection, USP
Approved
Approval ID
dfa26fd6-53dd-499c-8c40-fd0623d2c8f1
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 1, 2023
Manufacturers
FDA
Woodward Pharma Services LLC
DUNS: 080406260
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SODIUM ACETATE
PRODUCT DETAILS
NDC Product Code69784-232
Application NumberANDA214805
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 1, 2023
Generic NameSODIUM ACETATE
INGREDIENTS (3)
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM ACETATEActive
Quantity: 328 mg in 1 mL
Code: 4550K0SC9B
Classification: ACTIR
SODIUM ACETATE
PRODUCT DETAILS
NDC Product Code69784-230
Application NumberANDA214805
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 1, 2023
Generic NameSODIUM ACETATE
INGREDIENTS (3)
SODIUM ACETATEActive
Quantity: 164 mg in 1 mL
Code: 4550K0SC9B
Classification: ACTIR
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM ACETATE
PRODUCT DETAILS
NDC Product Code69784-231
Application NumberANDA214805
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 1, 2023
Generic NameSODIUM ACETATE
INGREDIENTS (3)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM ACETATEActive
Quantity: 164 mg in 1 mL
Code: 4550K0SC9B
Classification: ACTIR